Protein Conjugates

Patent No. EP3355931 (titled "Protein Conjugates") was filed by Novo Nordisk on Sep 30, 2016. The application was issued on Jun 26, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
JAMES POOLEMar 26, 2025CARPMAELS & RANSFORD

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Get instant alerts for new documents

EP3355931

NOVO NORDISK
Filing Date
Sep 30, 2016
Status
Granted
Publication Date
Jun 26, 2024